Navigating the Drug Development Process: Taking Your Asset From Lab to Patient

Navigating the Drug Development Process: Taking Your Asset From Lab to Patient

Unknown-2

 

September 22, 2015, Philadelphia, PA:  The Irish American Business Chamber Network is announcing a breakfast panel discussion on October 7th, at the Union League in Philadelphia. Sign up is at http://tinyurl.com/pxmjutc

 

This distinctive symposium provides local pharmaceutical and biotechnology innovators direct access to industry leaders with experience in preparing companies for the scientific, logistical, manufacturing and commercial challenges of taking a promising therapy from lab to the patient. Whether your ultimate goal is securing a partnership or successfully navigating your way through the clinical drug development process on your way to achieving commercial success, this symposium is for you.

 

UnknownPlanned as an interactive audience discussion, the morning will feature clinical drug development and commercial industry experts that will discuss the challenges of making medicines here in the US for distribution overseas, and the increasing attention being given to manufacturing products outside the United States.  Sign up can be done through the link below.

 

Unknown-14McDay is pleased that client Dr. Paul Shields of Enteris Bio and long-time friend Allison Cacciatore, Director of Biologics, Genzyme, Framingham will join the panel.